| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3822895 | Progrès en Urologie | 2013 | 12 Pages |
Abstract
Armamenterium to treat urethral dysfunctions has recently increases. Two new therapeutic classes emerge: PDE5Is to treat LUTS related to BPH and an SRIs (Duloxetine) to treat stress urinary incontinence. Efficacy and safety evaluation of all the possible associations between drugs targeting urethra and/or bladder is needed to a subtler and more efficient pharmacologic modulation of lower urinary tract dysfunction.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
X. Game, J.-N. Cornu, G. Robert, A. Descazeaud, S. Droupy, A. Benard-Laribiere, C. Bastide, L. Guy, F. Bruyére, G. Karsenty,